What outcomes are important to patients with mild cognitive impairment or Alzheimer’s disease, their caregivers, and health-care professionals? A systematic review
<br><strong>Introduction: </strong>Clinical trials involving patients with Alzheimer’s disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease m...
Main Authors: | Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, IF, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, MH, Reed, C, Roncancio-Diaz, E, Vos, S, Sudlow, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube
by: Janssen, O, et al.
Published: (2020) -
Conducting public involvement in dementia research: the contribution of the European Working Group of People with Dementia to the ROADMAP project
by: Diaz, A, et al.
Published: (2021) -
Health outcome prioritisation in Alzheimer’s disease: understanding the ethical landscape
by: McKeown, A, et al.
Published: (2020) -
Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol
by: Landeiro, F, et al.
Published: (2018) -
Challenges for optimizing real-world evidence in Alzheimer’s disease: The ROADMAP Project
by: Gallacher, J, et al.
Published: (2019)